In a first, researchers generate a direct measurement of the interaction between immune cells and cancer cells from a patient’s biopsy
Bar-Ilan UniversityResearchers at Bar-Ilan University have unveiled a technology that promises to improve cancer treatment decisions based on a patient's biopsy. Funded by the Israel Cancer Association, the pioneering biological research and development measures changes in immune system cells adjacent to cancer cells, providing crucial insights into the patient's immune response and potentially enhancing the effectiveness of immunotherapy.